Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Latrepirdine

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Parkinson’s Disease Dementia

living with dementia1 - the gerontologist1 - pomegranate1 - rem-sleep behavior disorder1 - cholinesterase inhibitors1 - abnormal tau protein1 - learning1 - emotional lability1 - boissier de sauvages2 - world alzheimers day1 - wernicke syndrome1 - stages of atherosclerosis1 - mildcognitive impairment1 - microrna1 - brain functions in patients1 - people with parkinsons1 - stress management1 - antihypertensive drugs1 - difficulties with swallowing1 - mediterranean diet1 - parkinsons5 - structural changes1 - progression of dementia1 - alpha-synuclein7 - tuberculosis1 - berrios and freeman1 - spect1 - computerized tomography1 - psychotic symptoms1 - cardiovascular disease1 -